Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.
Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D; IPMDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. Hoogland J, et al. Mov Disord. 2018 Nov;33(11):1750-1759. doi: 10.1002/mds.110. Epub 2018 Sep 14. Mov Disord. 2018. PMID: 30216541 Free PMC article. Review.
A central executive deficit in patients with Parkinson's disease.
Dalrymple-Alford JC, Kalders AS, Jones RD, Watson RW. Dalrymple-Alford JC, et al. J Neurol Neurosurg Psychiatry. 1994 Mar;57(3):360-7. doi: 10.1136/jnnp.57.3.360. J Neurol Neurosurg Psychiatry. 1994. PMID: 8158188 Free PMC article.
Characterizing mild cognitive impairment in Parkinson's disease.
Dalrymple-Alford JC, Livingston L, MacAskill MR, Graham C, Melzer TR, Porter RJ, Watts R, Anderson TJ. Dalrymple-Alford JC, et al. Mov Disord. 2011 Mar;26(4):629-36. doi: 10.1002/mds.23592. Epub 2011 Feb 1. Mov Disord. 2011. PMID: 21287603
α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.
Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF; SNCA Cognition Study Group; Goldman JG, Dalrymple-Alford JC, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ. Guella I, et al. Ann Neurol. 2016 Jun;79(6):991-9. doi: 10.1002/ana.24664. Epub 2016 May 5. Ann Neurol. 2016. PMID: 27091628 Free article.
Mild cognitive impairment as a risk factor for Parkinson's disease dementia.
Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. Hoogland J, et al. Mov Disord. 2017 Jul;32(7):1056-1065. doi: 10.1002/mds.27002. Epub 2017 Jun 12. Mov Disord. 2017. PMID: 28605056
141 results